PD-L1 Expression with Epithelial Mesenchymal Transition of Circulating Tumor Cells Is Associated with Poor Survival in Curatively Resected Non-Small Cell Lung Cancer

Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics

(2018) Kathleen A. Cronin et al.   CANCER

PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab

(2018) Nicolas Guibert et al.   LUNG CANCER

Intraoperative detection of circulating tumor cells in pulmonary venous blood during metastasectomy for colorectal lung metastases

(2018) Uyen-Thao Le et al.   Scientific Reports

Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy

(2018) Chunyan Yue et al.   OncoImmunology

PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system?

(2017) Cristina Raimondi et al.   OncoImmunology

Perioperative circulating tumor cell detection: Current perspectives

(2016) Jussuf T. Kaifi et al.   CANCER BIOLOGY & THERAPY

Epithelial-Mesenchymal Transition and Immune Evasion during Lung Cancer Progression: The Chicken or the Egg?

(2016) I. Datar et al.   CLINICAL CANCER RESEARCH

Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma

(2016) Y. Lou et al.   CLINICAL CANCER RESEARCH

PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysis

(2016) Sara Gandini et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung

(2016) Sehui Kim et al.   HUMAN PATHOLOGY

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

(2016) Roy S Herbst et al.   LANCET

Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients

(2016) Arun Satelli et al.   Scientific Reports

Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab

(2016) Chiara Nicolazzo et al.   Scientific Reports

Multi-Phenotypic subtyping of circulating tumor cells using sequential fluorescent quenching and restaining

(2016) Daniel L Adams et al.   Scientific Reports

Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques

(2015) Jussuf T Kaifi et al.   CANCER BIOLOGY & THERAPY

Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells

(2015) Abdullah Alsuliman et al.   Molecular Cancer

Frequent expression of PD-L1 on circulating breast cancer cells

(2015) Martine Mazel et al.   Molecular Oncology

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

(2015) Edward B. Garon et al.   NEW ENGLAND JOURNAL OF MEDICINE

The detection of EpCAM+ and EpCAM– circulating tumor cells

(2015) Sanne de Wit et al.   Scientific Reports

The mutually regulatory loop of epithelial–mesenchymal transition and immunosuppression in cancer progression

(2015) Limo Chen et al.   OncoImmunology

Epithelial-Mesenchymal Transitioned Circulating Tumor Cells Capture for Detecting Tumor Progression

(2014) A. Satelli et al.   CLINICAL CANCER RESEARCH

Tumor Plasticity Interferes with Anti-Tumor Immunity

(2014) Salem Chouaib et al.   CRITICAL REVIEWS IN IMMUNOLOGY

Cytometric characterization of Circulating Tumor Cells Captured by microfiltration and their correlation to the cellsearch®CTC test

(2014) Daniel L. Adams et al.   CYTOMETRY PART A

Cell-surface Vimentin: A mislocalized protein for isolating csVimentin+CD133−novel stem-like hepatocellular carcinoma cells expressing EMT markers

(2014) Abhisek Mitra et al.   INTERNATIONAL JOURNAL OF CANCER

Circulating giant macrophages as a potential biomarker of solid tumors

(2014) Daniel L. Adams et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression

(2014) Limo Chen et al.   Nature Communications

Molecular Biomarkers of Cancer Stem/Progenitor Cells Associated with Progression, Metastases, and Treatment Resistance of Aggressive Cancers

(2013) M. Mimeault et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Flexible Micro Spring Array Device for High-Throughput Enrichment of Viable Circulating Tumor Cells

(2013) R. A. Harouaka et al.   CLINICAL CHEMISTRY

The systematic study of circulating tumor cell isolation using lithographic microfilters

(2013) Daniel L. Adams et al.   RSC Advances

EMT and Dissemination Precede Pancreatic Tumor Formation

(2012) Andrew D. Rhim et al.   CELL

Nuclear expression of N-cadherin correlates with poor prognosis of nasopharyngeal carcinoma

(2012) Wei-Ren Luo et al.   HISTOPATHOLOGY

Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma

(2012) Weiren Luo et al.   INTERNATIONAL JOURNAL OF CANCER

Circulating Tumor Cells in Melanoma Patients

(2012) Gary A. Clawson et al.   PLoS One

Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer

(2011) A Lecharpentier et al.   BRITISH JOURNAL OF CANCER

B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells

(2008) T. Azuma et al.   BLOOD

Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design

(2008) Margaret S. Pepe et al.   JNCI-Journal of the National Cancer Institute